The Asia Pacific Consortium on Osteoporosis (APCO), comprising 39 clinical experts from 19 countries and regions across Asia Pacific (APAC), and its proposed ‘Framework’ aims to drive, and facilitate benchmarking for the provision of quality osteoporosis care across the region. According to a co-authored APCO member and Chair viewpoint article published on Monday, June 22,…

Read More

How to avoid faux pas & respect your fellow zoomies Working from home presents unique challenges and opportunities for those fortunate enough to be able to do so. Businesses and their employees are doing their best to navigate these unprecedented times, so it’s important to practice patience and respect. Here at VIVA! we are doing…

Read More

Today, VIVA! partnered with Celgene, a Bristol-Myers Squibb company, Multiple Myeloma Australia and Multiple Myeloma New Zealand to announce a newly reimbursed treatment option for Australians and New Zealanders living with incurable blood cancer, multiple myeloma. REVLIMID® (lenalidomide) – the first and only maintenance treatment in ANZ specifically indicated and reimbursed for those with newly…

Read More

Our own VIVA! Communications Principal and owner, Kirsten Bruce, Sydney was quoted in pharmaceutical industry publication, Pharma in Focus today on how to engage with staff working from home during the current COVID-19 pandemic. She cited the importance of corporate messaging being “clear, concise and reassuring to their employees, customers and stakeholders alike, explaining that…

Read More

VIVA! Communications is delighted to be teaming with UCB today (Thursday, March 26, 2020) to highlight the serious injuries caused by epileptic seizures, and call for heightened awareness, understanding and support for the 250,000 Australians living with epilepsy. One in 10 Australians living with epilepsy experience a seizure-related injury each year, many of which are…

Read More